| Hans-Günter Meyer-Thompson | international
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot.
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot.
Treloar C, Lancaster K, Gendera S, Rhodes T, Shahbazi J, Byrne M, Degenhardt L, Farrell M.
Int J Drug Policy. 2022 Jul 8;107:103788. doi: 10.1016/j.drugpo.2022.103788. Epub ahead of print. PMID: 35816790.
https://www.sciencedirect.com/science/article/abs/pii/S0955395922002043